Similarly, in MASH, uric acid and high-mobility group box 1 protein (HMGB1) are increased in the early phase, and with subsequent progression of the disease, the level of endotoxin and ATP increases [31]. This evidence concerns the gene HMGB1 and metabolic dysfunction-associated steatohepatitis.